Familial Hemiplegic Migraine with Severe Attacks: A New Report with ATP1A2 Mutation

E Martínez1, R Moreno2, L López-Mesonero1

  • 1Neurology Department, Hospital Clínico Universitario, Valladolid, Spain.

Insights

This study identifies a novel ATP1A2 gene mutation (p.Thr364Met) in a patient with severe familial hemiplegic migraine (FHM). This finding links specific ATP1A2 variants to prolonged FHM attacks and associated brain hypoperfusion.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura, characterized by neurological deficits, particularly motor weakness.
  • Genetic mutations in CACNA1A, ATP1A2, SCN1A, and PRRT2 genes are known causes of FHM.
  • Understanding the genetic basis of FHM is crucial for diagnosis and potential therapeutic strategies.

Purpose of the Study:

  • To investigate a specific mutation in the ATP1A2 gene in a patient presenting with particularly severe and prolonged symptoms of familial hemiplegic migraine.
  • To correlate the identified genetic variant with the clinical presentation and neuroimaging findings.

Main Methods:

  • Case study of a 22-year-old female with a history of hemiplegic migraine episodes.
  • Clinical assessment including neurological examination, fever, decreased consciousness, aphasia, and hemiplegia.
  • Neuroimaging techniques including Computed Tomography (CT) and CT perfusion study, alongside Magnetic Resonance (MR) imaging.
  • Genetic analysis to identify mutations in the ATP1A2 gene, with pathogenicity prediction using SIFT, PolyPhen2, MutationTaster, and Condel algorithms.

Main Results:

  • The patient experienced severe migraine attacks with right-sided weakness, aphasia, decreased consciousness, and hemiplegia, with symptoms lasting up to 10 days.
  • CT perfusion revealed oligohemia in the left hemisphere, while initial CT and subsequent MR imaging showed no structural lesions.
  • A heterozygous variant in the ATP1A2 gene (p.Thr364Met) was identified and predicted to be pathogenic.
  • Symptoms improved within days, with residual mild aphasia and hemiparesis resolving over 10 days, and no recurrence during a two-year follow-up.

Conclusions:

  • The ATP1A2 gene mutation p.Thr364Met is associated with severe and prolonged familial hemiplegic migraine attacks.
  • Diffuse hypoperfusion observed in FHM may be specifically linked to mutations within the ATP1A2 gene.
  • The identified p.T364M variant should be considered in the genetic diagnosis of FHM with severe and prolonged symptomatology.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.2K
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
16.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
607
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.2K
ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
6.7K
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
5.0K